Abstract
Pain is a crucial survival mechanism that alerts the body of danger. Following injury, acute pain is felt in the area specific to the site of injury and persists until the wound has healed. However, sometimes acute pain develops into chronic pain long after the organic healing process has come to an end. Treating pain often requires the use of opioids, which are highly addictive psychoactive substances. Opioids are used for their rapid and highly effective analgesic effects. The topic of chronic pain is widely studied and quite complex, while the study of addiction is equally dense. This chapter focuses on how pain and opiate addiction intertwine to provide the reader with a glimpse into the clinical implications of pain and addiction.
Keywords
- Chronic Pain
- Methadone Maintenance Treatment
- Chronic Pain Patient
- Chronic Pain Condition
- Prescription Opioid
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Adalf E, Paglia-Boak A, Brands B (2006) Use of oxycontin by adolescent students. CMAJ 174:1303
Altier N, Stewart J (1999) The role of dopamine in the nucleus accumbens in analgesia. Life Sci 65:2269–2287
Bailey J, Hurley R, Gold M (2010) Crossroads of pain and addiction. Pain Med 11:1803–1818
Behkit MH (2010) Opioid-induced hyperalgesia and tolerance. Am J Ther 17:498–510
Blondell R, Ashrafioun L (2008) Treating opioid dependency and coexistent chronic non-malignant pain. Am Fam Physician 78:1132–1133
Chauvin M, Beaulieu P (2005) Pharmacologie des opioïdes. In: Beaulieu P (ed) Pharmacologie de la douleur. Les Presses de l’Université de Montréal, Montréal, pp 39–77
Chou R (2009) Clinical guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain. Pol Arch Med Wewn 119:469–477
Christie MJ (2008) Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol 154:384–396
Coluzzi F, Mattia C (2005) Oxycodone: pharmacological profile and clinical data in chronic pain management. Minerva Anestesiol 71:451–460
Comer SD, Sullivan MA, Vosburg SK et al (2010) Abuse liability of oxycodone as a function of pain and drug use history. Drug Alcohol Depend 109:130–138
Comer S, Sullivan M, Whittington R et al (2008) Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers. Neuropsychopharmacology 33:1179–1191
Compton W, Volkow N (2006) Major increases in opioid analgesic abuse in the Unites States: concerns and strategies. Drug Alcohol Depend 81:103–107
Darke S (2011) Oxycodone poisoning: not just the usual suspects. Addiction 106:1035–1036
Doverty M, White JM, Somogyi A et al (2001) Hyperalgesic responses in methadone maintenance patients. Pain 90:91–96
DuPen A, Shen D, Ersek M (2007) Mechanisms of opioid-induced tolerance and hyperalgesia. Pain Manag Nurs 8:113–121
Hay JL, White JM, Bochner F et al (2009) Hyperalgesia in opioid managed chronic pain and opioid dependent patients. J Pain 10:316–322
Ives T, Chelminski P, Hammett-Stabler C et al (2006) Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res 4:1–10
Jayawant S, Balkrishnan R (2005) The controversy surrounding oxycontin abuse: issues and solutions. Ther Clin Risk Manag 1:77–82
Jung B, Reidenberg M (2007) Physicians being deceived. Pain Med 8:433–437
Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35:217–238
Kosten T, George T (2002) The neurobiology of opioid dependence: implications for treatment. Sci Pract Perspect 1:13–20
Le Bars D, Dickenson AH, Besson JM (1979) Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurons in the rat. Pain 6:283–304
Le Bars D, Dickenson AH, Besson JM (1979) Diffuse noxious inhibitory controls (DNIC). II, Lack of effect on non-convergent neurones, supraspinal involvement and theoretical implications. Pain 6:305–327
Leknes S, Lee M, Berna C et al (2011) Relief as reward: hedonic and neural responses to safety from pain. PLoS One 6:e17870
Leknes S, Tracey I (2008) A common neurobiology for pain and pleasure. Nature 9:314–320
Ling W, Mooney L, Hillhouse M (2011) Prescription opioid abuse, pain and addiction: clinical issues and implications. Drug Alcohol Rev 30:300–305
Lofwall M, Moody D, Fang B et al (2012) Pharmacokinetics of intranasal crushed oxycontin and intravenous oxycodone in nondependent prescription opioid abusers. J Clin Pharmacol 52:600–606
Manchikanti L, Singh A (2008) Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 11:S63–S88
Marchand S (2008) The physiology of pain mechanisms: from the periphery to the brain. Rheum Dis Clin North Am 34:285–309
Okie S (2010) A flood of opioids, a rising tide of deaths. N Engl J Med 18:1981–1985
Papaleontiou M, Henderson C, Turner B et al (2010) Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 58:1353–1369
Pasero C, McCaffery M (2004) Controlled-released oxycodone. Am J Nurs 104:30–32
Pattinson KTS (2008) Opioids and the control of respiration. Br J Anaesth 100:747–758
Potvin S, Benzaliouad F, Rompré PP (2010) Chapitre 15: La toxicomanie: drogues psychotropes. In: Beaulieu P, Lambert C (eds) Précis de Pharmacologie. Presses de l’Université de Montréal, Montréal, pp 399–420
Potvin S, Grignon S, Marchand S (2009) Human evidence of a supra-spinal modulating role of dopamine on pain perception. Synapse 63:390–402
Prosser JM, Steinfeld M, Cohen LJ et al (2008) Abnormal heat and pain perception in remitted heroin dependence months after detoxification from methadone-maintenance. Drug Alcohol Depend 95:237–244
Pud D, Cohen D, Lawental E, Eisenberg E (2006) Opioids and abnormal pain perception: new evidence from a study of chronic opioid addicts and healthy subjects. Drug Alcohol Depend 82:218–223
Rawson R, Maxwell J, Rutkowski B (2007) Oxycontin abuse: who are the users. Am J Psychiatry 164:1634–1636
Ren ZY, Shi J, Epstein DH et al (2009) Abnormal pain response in pain-sensitive opiate addicts after prolonged abstinence predicts increased drug craving. Psychopharmacology 204:423–429
Silverman SM (2009) Opioid induced hyperalgesia: clinical implications for the pain practitioner. Pain Physician 12:679–684
Sindrup S, Jensen T (1999) Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83:389–400
Sproule B, Brands B, Li S, Catzz-Biro L (2009) Changing patterns in opioid addiction. Can Fam Physician 55:68–69.e1–e5
Takala A, Kaasalainen V, Seppala T et al (1997) Pharmacokinetic comparison of intravenous and intranasal administration of oxycodone. Acta Anaesthesiol Scand 41:309–312
Turk D, Wilson H, Cahana A (2011) Treatment of chronic noncancer pain. Lancet 377:2226–2235
Welliver M (2010) Pharmacological intervention: reversal of sedation. Gastroenterol Nurs 33:446–447
White JM (2004) Pleasure into pain: the consequences of long-term opioid use. Addict Behav 29:1311–1324
Willer JC, Bouhassira D, Le Bars D (1999) Neurophysiological bases of the counterirritation phenomenon: diffuse control inhibitors induced by nociceptive stimulation. Neurophysiol Clin 29:379–400
Wise RA (2002) Brain reward circuitry: insights from unsensed incentives. Neuron 36:229–240
Zacny JP (2010) A possible link between sensation-seeking status and positive subjective effects of oxycodone in healthy volunteers. Pharmacol Biochem Behav 95:113–120
Zee AV (2009) The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health 99:221–227
Acknowledgments
SP is holder of a Junior 1 Young Investigator Award from the Fonds de Recherche du Québec en Santé, and receives financial support from the Centre de recherche Fernand-Seguin and the Louis-H Lafontaine Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag France
About this chapter
Cite this chapter
Stavro, K., Potvin, S. (2014). Opioids and Pain: The Dark Side of the Moon. In: Marchand, S., Saravane, D., Gaumond, I. (eds) Mental Health and Pain. Springer, Paris. https://doi.org/10.1007/978-2-8178-0414-9_13
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0414-9_13
Published:
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0413-2
Online ISBN: 978-2-8178-0414-9
eBook Packages: MedicineMedicine (R0)